Theralink Technologies, Inc.
THER
$0.0001
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 83.90K | 179.30K | 202.40K | 169.80K | 55.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 83.90K | 179.30K | 202.40K | 169.80K | 55.30K |
| Cost of Revenue | 85.70K | 59.80K | 69.10K | 30.60K | 42.50K |
| Gross Profit | -1.70K | 119.40K | 133.30K | 139.10K | 12.80K |
| SG&A Expenses | 1.55M | 2.46M | 1.82M | 2.29M | 2.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.63M | 2.51M | 1.89M | 2.32M | 2.63M |
| Operating Income | -1.55M | -2.34M | -1.68M | -2.15M | -2.58M |
| Income Before Tax | -19.05M | 9.62M | 4.50M | -8.57M | -36.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.05M | 9.62M | 4.50M | -8.57M | -36.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.05M | 9.62M | 4.50M | -8.57M | -36.46M |
| EBIT | -1.55M | -2.34M | -1.68M | -2.15M | -2.58M |
| EBITDA | -1.50M | -2.28M | -1.63M | -2.09M | -2.53M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 6.15B | 6.15B | 6.15B | 6.15B | 6.15B |
| Average Diluted Shares Outstanding | 6.15B | 6.15B | 21.15B | 6.15B | 6.15B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |